Did any adverse reactions happen during this study?
Benralizumab Placebo
(out of 207 participants) (out of 203 participants)
How many participants had adverse 15.0% (31) 5.9% (12)
reactions?
How many participants had serious adverse 1.4% (3) 0.0% (0)
reactions?
How many participants stopped taking 1.9% (4) 1.0% (2)
study treatment due to adverse reactions?
What serious adverse reactions happened during this study?
The table below shows the serious adverse reactions that happened during the
study.
Serious adverse reactions
Benralizumab Placebo
Serious adverse reaction (out of 207 participants) (out of 203 participants)
Immune system destroys red blood cells, 0.5% (1) 0.0% (0)
leading to low levels of red blood cells
Cancer of the salivary gland 0.5% (1) 0.0% (0)
Sudden inflammation of the pancreas 0.5% (1) 0.0% (0)
None of the participants died due to any serious adverse reactions during the
study.
13 | Clinical Study Results